Cargando…
Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
Cancer stem-like cells (CSC) represent a subpopulation of tumor cells with elevated tumor-initiating potential. Upon differentiation, they replenish the bulk of the tumor cell population. Enhanced tumor-forming capacity, resistance to antitumor drugs, and metastasis-forming potential are the hallmar...
Autores principales: | Marcucci, Fabrizio, Rumio, Cristiano, Lefoulon, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861739/ https://www.ncbi.nlm.nih.gov/pubmed/27242955 http://dx.doi.org/10.3389/fonc.2016.00115 |
Ejemplares similares
-
Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?
por: Marcucci, Fabrizio, et al.
Publicado: (2019) -
The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells
por: Marcucci, Fabrizio, et al.
Publicado: (2017) -
How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress—Therapeutic Implications
por: Marcucci, Fabrizio, et al.
Publicado: (2018) -
Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
por: Marcucci, Fabrizio, et al.
Publicado: (2021) -
Glycolysis-induced drug resistance in tumors—A response to danger signals?
por: Marcucci, Fabrizio, et al.
Publicado: (2021)